Other functional disturbances following cardiac surgery. I97.1
Conditions
Interventions
Intervention 1: Intervention group:Intervention group: Receiving 250 mg of magnesium oxide supplement tablets per day for 5 days from the time of hospitalization to the day of discharge. Magnesium tab
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 70 Years
Inclusion criteria
Inclusion criteria: Age less than 70 years Candidate for coronary artery bypass graft surgery No atrial fibrillation (normal sinus) No nausea and vomiting No liver and kidney failure No history of stroke or cerebral ischemic attack in one month
Exclusion criteria
Exclusion criteria: No willingness to participate in the study Emergency surgery Acute renal failure during the study Respiratory after surgery and the need for re-intubation inside the chip Chronic diarrhea Sensitivity to supplements History of sleep disorders, anxiety and depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Measuring the quality of sleep before prescribing magnesium supplements the day after surgery and the day of discharge from the hospital. Method of measurement: Pittsburgh questionnaire.;Anxiety. Timepoint: Measuring the anxiety and before prescribing magnesium supplements the day after surgery and the day of discharge from the hospital. Method of measurement: Anxiety Questionnaire.;Depreesion. Timepoint: Measuring depression before prescribing magnesium supplements the day after surgery and the day of discharge from the hospital. Method of measurement: Depreesion Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Saba
Bagheiat-allah University of Medical Sciences
Outcome results
None listed